PYCR1 and renal cell adenocarcinoma: Works in the literature and pan-cancer analyses indicate that PYCR1 is commonly upregulated in various cancers, including kidney adenocarcinoma, gastric cancer, lung cancer, pancreatic ductal adenocarcinoma, renal cell carcinoma, breast cancer, and hepatocellular carcinoma.